SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway by Willett, BJ, Grove, J, MacLean, OA, Klenerman, P, Dunachie, S, Barnes, E, Brown, A, Adele, S, Kronsteiner, B, Murray, SM, Abraham, P, Deeks, A, Ansari, MA, Fraser, C, Bonsall, D, Fryer, H, Lythgoe, K, Thomson, L, Golubchik, T, Underwood, AP, Taylor, BEW, Yeats, CA, Aanensen, DM, Abudahab, K, Menegazzo, M, Zarebski, AE, Gutierrez, B, Raghwani, J, du Plessis, L, Kraemer, MUG, Pybus, OG, Francois, S, Attwood, SW, Vasylyeva, TI, Trebes, A, Green, A, Buck, D, MacIntyre-Cockett, G, Todd, JA

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination by Liew, F, Talwar, S, Cross, A, Willett, BJ, Scott, S, Logan, N, Siggins, MK, Swieboda, D, Sidhu, JK, Efstathiou, C, Moore, SC, Davis, C, Mohamed, N, Nunag, J, King, C, Thompson, AAR, Rowland-Jones, SL, Docherty, AB, Chalmers, JD, Ho, L-P, Horsley, A, Raman, B, Poinasamy, K, Marks, M, Kon, OM, Howard, L, Wootton, DG, Dunachie, S, Quint, JK, Evans, RA, Wain, LV, Fontanella, S, de Silva, TI, Ho, A, Harrison, E, Baillie, JK, Semple, MG, Brightling, C, Thwaites, RS, Turtle, L, Openshaw, PJM